Should new organ involvement be included in Response Evaluation Criteria in PSMA Imaging?-Reference-Cited by-同舟云学术

Should new organ involvement be included in Response Evaluation Criteria in PSMA Imaging?

Published:2024-06-16 Issue:10 Volume:38 Page:825-834
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Kaplan İhsan^ORCID,Kömek Halil,Can Canan,Akdeniz Nadiye,Güzel Yunus,Kepenek Ferat,Şenol Ayhan,İleri Serdar,Karaoğlan Hüseyin,Solmaz İhsan,Yıldırım Mehmet Serdar,Şenses Veysi,Kaya Fulya,Gündoğan Cihan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12149-024-01954-0.pdf

Reference28 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

2. Zang S, Shao G, Cui C, Li TN, Huang Y, Yao X, et al. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients. Oncotarget. 2017;8:12247–58.

3. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Hell J Nucl Med. 2019;22:6–9.

4. Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, et al. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. Eur J Nucl Med Mol Imaging. 2021;48:1626–38.

5. Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50:1466–86.